The expression of DTL was significantly associated with clinical stage in the LIHC and BLCA cohorts, (Fig. 6F-G and Tables 1, 2 and 3), while not in the STAD cohort (Table 3), which was consistent with the results of the TCGA cohort. Here, DTL is linked to bladder transitional cell carcinoma.